Q4

Bharat Parenterals Ltd

BPLPHARMAFY2618 May 2026

Revenue+52.8%

Net Profit+15.6%

OPM-0.53%

P&L

Quarterly Consolidated

Revenue

+52.8%99.62

Expenditure

+49.2%111.62

Net Profit

+15.6%-8.16

NPM -7.90%+45.7%EPS ₹11.84-15.6%

vs Q3 FY26

Informational and educational content only. Not investment advice.